Colombia vs Costa Rica: Reported rate of new cervical cancer cases
Colombia
13.01 per 100,000 women
in 2017
Costa Rica
11.71 per 100,000 women
in 2016
Colombia rank
8th
Costa Rica rank
11th
Reported rate of new cervical cancer cases over time
- Colombia
- Costa Rica
How they compare
Colombia currently reports 13.01 per 100,000 women against 11.71 per 100,000 women in Costa Rica, a difference of 1.3 per 100,000 women.
That makes Colombia's figure about 1.1 times Costa Rica's.
Across all 14 years both countries report, Colombia has been ahead every year.
Colombia ranks 8th and Costa Rica ranks 11th of 46 countries.
Colombia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Colombia | Costa Rica | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 19.18 per 100,000 women | 13.84 per 100,000 women | 5.34 per 100,000 women | Colombia |
| 2010s | 13.99 per 100,000 women | 11.86 per 100,000 women | 2.13 per 100,000 women | Colombia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported rate of new cervical cancer cases, Colombia or Costa Rica?
- Colombia, at 13.01 per 100,000 women against 11.71 per 100,000 women in Costa Rica as of 2017.
- What is the difference in reported rate of new cervical cancer cases between Colombia and Costa Rica?
- 1.3 per 100,000 women, with Colombia ahead.
- How many years of comparable data are there for Colombia and Costa Rica?
- 14 years are reported by both, from 2003 to 2016.
- How do Colombia and Costa Rica rank globally for reported rate of new cervical cancer cases?
- Colombia ranks 8th and Costa Rica ranks 11th of 46 countries.
- Where does this data come from?
- Global Cancer Observatory (2025) – processed by Our World in Data, published as Reported rate of new cervical cancer cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported number of new cervical cancer cases per 100,000 women, based on data from cancer registries. Comparisons may be affected by differences in measurement, including screening and diagnosis.